Acrx stock forecast.
Earnings announcement* for ACRX: May 15, 2023. AcelRx Pharmaceuticals, Inc. is estimated to report earnings on 05/15/2023. The upcoming earnings date is derived from an algorithm based on a ...
AcelRx Pharmaceuticals Inc. 0.6199. Delayed Data. As of Nov 21. +0.1189 / +23.73%. Today’s Change. 0.43. Today ||| 52-Week Range. 2.78. 14,241.02 -9.83(-0.07%) Russell 2000 1,801.15 -6.35(-0.35%) Crude Oil 75.02 -0.52(-0.69%) Gold 2,014.40 +11.40(+0.57%) Advertisement AcelRx Pharmaceuticals, Inc. (ACRX) …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Vistagen Therapeutics Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The ...Dec 1, 2023 · View AcelRx Pharmaceuticals, Inc ACRX investment & stock information. Get the latest AcelRx Pharmaceuticals, Inc ACRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.
Iterum Therapeutics plc (NASDAQ:ITRM) released its quarterly earnings results on Friday, November, 12th. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $1.80 by $1.50. During the same period last year, the company earned ($5.10) EPS. View the latest news, buy/sell ratings, SEC filings and …14,241.02 -9.83(-0.07%) Russell 2000 1,801.15 -6.35(-0.35%) Crude Oil 75.02 -0.52(-0.69%) Gold 2,014.40 +11.40(+0.57%) Advertisement AcelRx Pharmaceuticals, Inc. (ACRX) …
We are talking returns of at least 300% over the next 12 months, according to the analysts.AcelRx Pharmaceuticals (ACRX)Opioids have made headlines in recent years, and for all the wrong reasons ...EPS forecast (this quarter)-$0.48: Annual revenue (last year) $1.8M: Annual profit (last year) $42.5M: Net profit margin: 2,400.62%
1 Wall Street research analysts have issued 1-year price targets for Acurx Pharmaceuticals' stock. Their ACXP share price targets range from $13.00 to $13.00. On average, they predict the company's stock price to reach $13.00 in the next twelve months. This suggests a possible upside of 244.8% from the stock's current price.AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock quote, history, news and other vital information to help you with your stock trading and investing.What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.Iterum Therapeutics plc (NASDAQ:ITRM) released its quarterly earnings results on Friday, November, 12th. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $1.80 by $1.50. During the same period last year, the company earned ($5.10) EPS. View the latest news, buy/sell ratings, SEC filings and insider transactions ...
The image below, which you can click on for greater detail, shows that at December 2021 Achieve Life Sciences had debt of US$14.9m, up from none in one year. However, it does have US$43.0m in cash ...
AcelRx Pharmaceuticals (ACRX) Stock Forecast & Price Prediction. Estimation of the future price movement of AcelRx Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.
1 Wall Street research analysts have issued 1-year price objectives for Akari Therapeutics' stock. Their AKTX share price targets range from $30.00 to $30.00. On average, they predict the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 906.7% from the stock's current price.Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Verona Pharma PLC have a median target of 32.00, with a high estimate of 38.00 and a low estimate of 31.00. The median ...See AcelRx Pharmaceuticals, Inc. (ACRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Oct 2, 2023 · AcelRx Pharmaceuticals is forecast to grow earnings and revenue by 11.4% and 63.5% per annum respectively while EPS is expected to grow by 33.4% per annum. What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system. 2 Wall Street analysts have issued twelve-month price targets for AcelRx Pharmaceuticals' stock. Their ACRX share price targets range from $4.25 to $5.00. On average, they expect the company's share price to reach $4.63 in the next twelve months. This suggests a possible upside of 670.8% from the stock's current price. Earnings for AcelRx Pharmaceuticals are expected to decrease in the coming year, from ($0.40) to ($0.65) per share. AcelRx Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year's report dates. Read More.
SmartAssetPaid Partner. Find real-time CTMX - CytomX Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock quote, history, news and other vital information to help you with your stock trading and investing.The sales figure was up 433% sequentially, and the total revenue figure was up 133% year-over-year.Against this backdrop, several members of the Street believe ACRX’s $1.40 share price looks ...Stock Price Forecast The 5 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 4.00. Sep 26, 2023 · On September 26, 2023, an intriguing block trade took place involving ACRX, a security with a trading price of $0.55. Find real-time ATHX:US - Athersys Inc stock quotes, company profile, news and forecasts from CNN Business.
5 equities research analysts have issued 1 year price targets for Hanesbrands' stock. Their HBI share price targets range from $5.00 to $7.00. On average, they expect the company's stock price to reach $5.75 in the next year. This suggests a possible upside of 56.7% from the stock's current price.
We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...On September 26, 2023, an intriguing block trade took place involving ACRX, a security with a trading price of $0.55.The reverse stock split will become effective at 5:01 p.m. ET on Tuesday, October 25, 2022. AcelRx's common stock will continue to be traded on the Nasdaq Global Market under the symbol ACRX and ...AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast The 2 analysts offering 12-month price forecasts for Acurx Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 13.00 and a low estimate of 10.00.AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock quote, history, news and other vital information to help you with your stock trading and investing.EPS forecast (this quarter)-$0.48: Annual revenue (last year) $1.8M: Annual profit (last year) $42.5M: Net profit margin: 2,400.62%The image below, which you can click on for greater detail, shows that at December 2021 Achieve Life Sciences had debt of US$14.9m, up from none in one year. However, it does have US$43.0m in cash ...
The Applied Science Products, Inc. stock price gained 11.13% on the last trading day (Friday, 1st Dec 2023), rising from $4.67 to $5.19. During the last trading day the stock fluctuated 13.23% from a day low at $4.65 to a day high of $5.27. The price has risen in 6 of the last 10 days and is up by 21.26% over the past 2 weeks.
Track Asensus Surgical Inc (ASXC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now.Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for ACRX stock stock is $4.63, which predicts an increase of …Oct 20, 2023 · ACRX stock had an impressive performance on October 20, 2023, with the potential for significant growth in the future. According to data from CNN Money, two analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 4.63, with a high estimate of 5.00 and a low estimate of 4.25. ACRX Stock 12 Months Forecast. $5.00. (624.74% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Acelrx in the last 3 months. The average price target is $5.00 with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a 624.74% change from the last price of $0.69. Find real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Sign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023. Next Earnings (Estimated) +423.4%. $-26,640,000.00.
Revolution Medicines, Inc. (RVMD), another stock in the Zacks Medical - Drugs industry, is expected to report earnings per share of $0.84 for the quarter ended March 2023. This estimate points to ...Share $0.69 After Hours: $0.75 (9.34%) +0.064 Closed: Nov 29, 4:02:05 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Trevena Inc $0.58 TRVN1.05% DURECT Corp $0.65 DRRX4.33% Pieris...ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Instagram:https://instagram. jepi ex dividend date 2023lbndxsony corporation stockpublicly traded solar companies Find the latest Amplify Energy Corp. (AMPY) stock quote, history, news and other vital information to help you with your stock trading and investing. individual legal insurancemichael jordan autographed 14,241.02 -9.83(-0.07%) Russell 2000 1,801.15 -6.35(-0.35%) Crude Oil 75.02 -0.52(-0.69%) Gold 2,014.40 +11.40(+0.57%) Advertisement AcelRx Pharmaceuticals, Inc. (ACRX) NasdaqGM - NasdaqGM Real... Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ... dna applied sciences Their ACRX share price targets range from $4.25 to $5.00. On average, they predict the company's stock price to reach $4.63 in the next twelve months. This …Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ...Find real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.